annamycin
Moleculin Accelerates Outlook Into 2026 With First Pivotal Trial Unblinding on Track, Global Trial Expansion, and Multiple Externally/IIT Funded Clinical Programs
Moleculin; MIRACLE trial; Annamycin; WP1066; AML; clinical trials; 2026 milestones